EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Phases and Natural History of Sjögren's Disease: A New Model for an Old Disease?

Adrian Y S Lee iD, Jing Jing Wang, Tom P Gordon, Joanne H Reed

Arthritis Care & Research · 2023-07 · 75 (7) · 1580-1587

DOI: 10.1002/acr.25011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arthritis Care & Research, online erschienen am 05.01.2023. Verfasst von Adrian Y S Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Westmead Institute for Medical Research, University of Sydney, Westmead Hospital, NSW Health Pathology, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Autoimmune Diseases, Lymphoma. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjögren's disease (SjD) is an archetypal and heterogenous autoimmune disorder that is characterized by exocrine glandular dysfunction. A proportion of patients develop severe extraglandular manifestations, such as cryoglobulinemia, and have an increased risk of lymphoma, both of which can adversely affect quality of life and occasionally mortality. As with most autoimmune disorders, the pathogenesis is poorly understood and difficult to predict, and, frustratingly, there is a lack of targeted therapies to cure this disease. We review the disease manifestations of SjD and propose a staged model for understanding the evolution of pathology. In longitudinal studies, most patients remain relatively stable in terms of their laboratory and clinical parameters. However, in the setting of various risk factors, a proportion of patients develop severe symptoms and/or lymphoma. We discuss potential underlying mechanisms for disease progression and the strengths and limitations of using a staged model to correlate the pathogenesis and spectrum of manifestations in SjD. Ultimately, understanding how and why some patients remain relatively stable, whereas others progress and develop florid systemic disease and a fraction develop lymphoma, is key to developing preventative and therapeutic treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeAutoimmune DiseasesLymphomaHumansQuality of LifeRisk Factors

Autor:innen und Institutionen

  • The Westmead Institute for Medical Research, University of Sydney, Westmead Hospital, NSW Health Pathology, Westmead, New South Wales, Australia.
  • SA Pathology and Flinders University, Bedford Park, South Australia, Australia.
  • The Westmead Institute for Medical Research, University of Sydney, Westmead, New South Wales, Australia.

ORCID-Profile: Adrian Y S Lee

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Lee, A. Y. S., Wang, J. J., Gordon, T. P., & Reed, J. H. (2023). Phases and Natural History of Sjögren's Disease: A New Model for an Old Disease?. Arthritis Care & Research, 75(7), 1580-1587. https://doi.org/10.1002/acr.25011

Vancouver

Lee AYS, Wang JJ, Gordon TP, Reed JH. Phases and Natural History of Sjögren's Disease: A New Model for an Old Disease?. Arthritis Care & Research. 2023;75(7):1580-1587. doi:10.1002/acr.25011

BibTeX
@article{Lee2023,
  author = {Lee, Adrian Y S and Wang, Jing Jing and Gordon, Tom P and Reed, Joanne H},
  title = {Phases and Natural History of Sjögren's Disease: A New Model for an Old Disease?},
  journal = {Arthritis Care & Research},
  year = {2023},
  volume = {75},
  number = {7},
  pages = {1580--1587},
  doi = {10.1002/acr.25011}
}
Kostenlos starten →